Do you want to read an article? Please log in or register.
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
Macular Diseases
Related content
Glaucoma and Ocular Pressure
Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change: GLP-1 Receptor Agonists and Intraocular Pressure Change
Am J Ophthalmol
Hallaj S, Halfpenny W, Chuter BG, Weinreb RN, Baxter SL, Cui QN
doi: 10.1016/j.ajo.2024.08.030
Macular Diseases
Intravitreal anti-vascular endothelial growth factor injections and risks of stroke in patients with neovascular age-related macular degeneration-A registry-based cohort study
Acta Ophthalmol
Falemban AH, Söderberg-Löfdal K, Jonsson F, Almlöf-Sarman S, von Euler M, Westborg I
doi: 10.1111/aos.17534
Retinal Diseases
Impact of glucagon-like peptide-1 receptor agonists on diabetic retinopathy: A meta-analysis of clinical studies emphasising retinal changes as a primary outcome
Clin Exp Ophthalmol
Kapoor I, Sarvepalli SM, D'Alessio DA, Hadziahmetovic M
doi: 10.1111/ceo.14445
RECOMMENDED
Macular Diseases
Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Berni A, Coletto A, Li J, Shen M, Bandello F, Reibaldi M, Borrelli E
doi: 10.1016/j.oret.2025.01.011
Macular DiseasesFurther Publications
Subretinal fibrosis occurrence according to macular neovascularisation subtypes in neovascular age-related macular degeneration
Acta Ophthalmol
Lenhof S, Kodjikian L, Gascon P, Gadiollet E, Feldman A, De Bats F, Wolff B, Pradat P, Mathis T
doi: 10.1111/aos.16759
COMMENTED
Macular DiseasesRetinal Diseases
Psoriasis as a Predictor of Neovascular Age-Related Macular Degeneration in Type 2 Diabetes Mellitus: A Nationwide Cohort Study
★ 3
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Lee MY, Han K, Min KH, Yu DS, Lee YB
doi: 10.1016/j.ajo.2024.08.033
Macular Diseases
Efficacy and safety of brolucizumab every 6 weeks induction therapy for neovascular age-related macular degeneration
Sci Rep
Honda S, Maruyama-Inoue M, Otsuji T, Kyo A, Kobayashi Y, Yamamoto Y, Gomi F
doi: 10.1038/s41598-025-89638-1
Macular DiseasesFurther Publications
Curcuma-Based Nutritional Supplements and Risk of Age-Related Macular Degeneration
JAMA Ophthalmol
Alsoudi AF, Wai KM, Koo E, Mruthyunjaya P, Rahimy E
doi: 10.1001/jamaophthalmol.2024.4400
Macular Diseases
Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune Disease
JAMA Ophthalmol
Hallak JA, Abbasi A, Goldberg RA, Modi Y, Zhao C, Jing Y, Chen N, Mercer D, Sahu S, Alobaidi A, López FJ, Luhrs K, Waring JF, den Hollander AI, Smaoui N
doi: 10.1001/jamaophthalmol.2024.2376